retatrutide triple hormone receptor agonist metabolic for dysfunction-associated steatotic liver disease: a randomized phase 2a trial Eli Lilly: GLP-1R/GCGR/GIPR Triagonist Reduces
Pay in 4 interest-free payments of $6.74 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25














